Soligenix
SNGX
#11027
Rank
ยฃ3.99 M
Marketcap
ยฃ0.17
Share price
-6.82%
Change (1 day)
-83.08%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -ยฃ8.7 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ9.05 Million a decrease over its 2024 earnings that were of -ยฃ7.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ8.7 Million-3.92%
2025 -ยฃ9.05 Million26.72%
2024 -ยฃ7.14 Million22.96%
2023 -ยฃ5.81 Million-45.74%
2022 -ยฃ10.7 Million11.88%
2021 -ยฃ9.57 Million-32.37%
2020 -ยฃ14.14 Million83.18%
2019 -ยฃ7.72 Million11.57%
2018 -ยฃ6.92 Million19.29%
2017 -ยฃ5.8 Million33%
2016 -ยฃ4.37 Million-19.7%
2015 -ยฃ5.43 Million5.16%
2014 -ยฃ5.17 Million
2010 -ยฃ5.83 Million26.12%
2009 -ยฃ4.63 Million75.1%
2008 -ยฃ2.64 Million-45.38%
2007 -ยฃ4.84 Million-22.84%
2006 -ยฃ6.27 Million66.15%
2005 -ยฃ3.77 Million-16.65%
2004 -ยฃ4.53 Million13.28%
2003 -ยฃ4 Million-11.88%
2002 -ยฃ4.53 Million-59.44%
2001 -ยฃ11.17 Million378.18%
2000 -ยฃ2.34 Million-38.53%
1999 -ยฃ3.8 Million-18.43%
1998 -ยฃ4.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.29 B-160,056.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ5.32 B-59,636.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ5.94 B-66,642.75%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ13.87 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ31.9 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.93 B-10,558.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-ยฃ2.11 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-ยฃ0.15 Billion 1,562.71%๐Ÿ‡บ๐Ÿ‡ธ USA